1. Home
  2. GT vs MPLT Comparison

GT vs MPLT Comparison

Compare GT & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Goodyear Tire & Rubber Company

GT

The Goodyear Tire & Rubber Company

HOLD

Current Price

$5.71

Market Cap

1.6B

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$27.54

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GT
MPLT
Founded
1898
2018
Country
United States
United States
Employees
N/A
133
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
GT
MPLT
Price
$5.71
$27.54
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$9.13
$32.67
AVG Volume (30 Days)
8.9M
249.6K
Earning Date
05-06-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,280,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.43
$12.24
52 Week High
$12.03
$33.28

Technical Indicators

Market Signals
Indicator
GT
MPLT
Relative Strength Index (RSI) 34.06 46.56
Support Level $5.43 $26.20
Resistance Level $6.26 $31.88
Average True Range (ATR) 0.19 2.22
MACD 0.01 -0.24
Stochastic Oscillator 27.71 38.99

Price Performance

Historical Comparison
GT
MPLT

About GT The Goodyear Tire & Rubber Company

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: